Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Novavax Steals Some of Pfizer’s Thunder With Fast Track Designation

By Will Ashworth, InvestorPlace Contributor

Novavax delivered good news Nov. 9. It announced its Covid-19 vaccine’s been fast-tracked by the FDA. That’s very good news for NVAX stock.

Westwater Resources Insiders Need to Let Their Money Do the Talking

By Will Ashworth, InvestorPlace Contributor

Westwater Resources’ graphite potential is one thing. The fact that directors and management own less than 1% of WWR stock tells me another. 

Hyliion Stock Is Anything But a Must Buy Heading Into 2021

By Will Ashworth, InvestorPlace Contributor

The need to convert class 8 heavy-duty trucks is real. However, that doesn’t mean this reality makes Hyliion stock a must-buy. Here’s why.    

Caterpillar or Nikola: Which Is the Better Buy Heading Into 2021?

By Will Ashworth, InvestorPlace Contributor

Legend Capital Partners owns 13.1 million shares of Nikola. A man named Dewitt C. Thompson V controls Legend. Is NKLA stock his best buy?    

The Upside for Kensington Capital Stock Is North of 50%

By Will Ashworth, InvestorPlace Contributor

InvestorPlace’s Mark Hake argues that based on 2027 revenues, Kensington Capital stock is worth $18.70 a share. Here’s why he’s right.

For Hexo Stock, In God We Truss Might Be Its Best Bet

By Will Ashworth, InvestorPlace Contributor

Hexo has had to call for a reverse 8-for-1 Hexo stock split to bring its stock into compliance with NYSE. Truss Beverage could be its savior.

10 Cheap Stocks to Buy in November Under $10

By Will Ashworth, InvestorPlace Contributor

If you’re looking to buy an early holiday present for yourself, here are 10 cheap stocks to buy under $10 in November.

Avoid Desperate-Looking Kaixin Auto Like the Plague

By Will Ashworth, InvestorPlace Contributor

Kaixin Auto announced Nov. 5 that it’s merging with Haitoche, a China-based e-commerce platform. What does this mean for KXIN stock?    

I See the Glass Half Full for Fastly Stock Following Q3

By Will Ashworth, InvestorPlace Contributor

InvestorPlace’s Louis Navellier recommended waiting to buy Fastly until it announced Q3 earnings. Fastly stock fell on the news. Time to sell? 

Canopy Growth Is Thirsting for a Catalyst to Move Its Share Price Even Higher

By Will Ashworth, InvestorPlace Contributor

Forget cannabis and consider what Canopy Growth is doing with BioSteel energy drinks. It is a major value enhancer for CGC stock. Here’s why.

Load More